The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 11, 2014

Filed:

Jun. 14, 2013
Applicant:

Kineta Two Llc, Seattle, WA (US);

Inventors:

Shawn P. Iadonato, Seattle, WA (US);

Charles L. Magness, Seattle, WA (US);

Mark Branum, Bellevue, WA (US);

Maralee McVean, Seattle, WA (US);

Christina Scherer, Seattle, WA (US);

Assignee:

Kineta Two, LLC, Seattle, WA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/12 (2006.01); C12N 15/00 (2006.01); C12N 1/20 (2006.01); C07H 21/04 (2006.01); A61K 38/51 (2006.01); A61K 38/45 (2006.01); C12N 15/10 (2006.01);
U.S. Cl.
CPC ...
C12N 9/1241 (2013.01); C12N 15/102 (2013.01); A61K 38/45 (2013.01); C12Y 207/07 (2013.01);
Abstract

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.


Find Patent Forward Citations

Loading…